comparemela.com

Guna Kakulapati News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Startup funding: Dermatology startup Cureskin raises $20 million

The latest investment brings Cureskin s total funding to $26 million, further fuelling its vision to widen access to quality dermatological care in the country. In 2022, JSW Ventures had invested $5 million in the startup.

Technology leadershipIndian school of businessOffering collegeKhosla venturesSharrp venturesTech prowessHigh value skillGuna kakulapatiStartup fundingVenture capital

CureSkin snags $20 mn from healthcare-focussed VC firm HealthQuad

Consumer healthcare startup CureSkin has raised $20 million (around Rs 166 crore as per current rates) as a part of its Series B round, led ..

Sreeja biswasAntoine janssenCharu sharmaGoogle launchpad accelerator programmeHeallo indiaGuna kakulapatiKhosla venturesSharrp venturesRamakrishna rajannaCorporate advisorsQuadria capitalSubscribe nowJsw venturesSharrp venturesSreeja biswasVenture capital

Indian AI-driven skin care app CureSkin scores $5M in Series A funding

The startup plans to increase its user base and further invest in technology.

Indian association of dermatologistsIndian associationGuna kakulapati

CureSkin raises $5 Mn in a round led by JSW Ventures

New Delhi: CureSkin, artificial intelligence-driven beauty and personal care brand, has raised $5 Mn in a Series A round led by JSW Ventures with participation from Sharrp Ventures, SenseAI and other existing investors. CureSkin plans to deploy thes

New delhiSachin tagraIndian association of dermatologistsSharrp venturesIndian associationIndian dermatologistsGuna kakulapati

AI-Driven Startup CureSkin Secures $5 Mn In Series A From JSW Ventures

Bengaluru-based CureSkin, an AI-driven beauty and personal care startup, has raised $5 Mn in a Series A round led by JSW Ventures

Sachin tagraCharu sharmaGood glamm groupBengaluru based cureskinGuna kakulapatiRamakrishna rajannaSugar cosmeticsGood vibesElevation capital

vimarsana © 2020. All Rights Reserved.